Agenda of the CAT meeting 6-8 November 2024
Submitted by Anonymous (not verified) on 6 November 2024 - 7:28
Agenda of the CAT meeting 6-8 November 2024
Veterinary medicines European public assessment report (EPAR): Porcilis ColiClos, vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 16:52
Veterinary medicines European public assessment report (EPAR): Porcilis ColiClos, vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs, Status: Authorised
Veterinary medicines European public assessment report (EPAR): ArthriCox, firocoxib, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 16:48
Veterinary medicines European public assessment report (EPAR): ArthriCox, firocoxib, Status: Authorised
Agenda of the COMP meeting 5-7 November 2024
Submitted by Anonymous (not verified) on 5 November 2024 - 16:45
Agenda of the COMP meeting 5-7 November 2024
Veterinary medicines European public assessment report (EPAR): Cirbloc M Hyo, mycoplasma hyopneumoniae, strain 2940, inactivated,porcine circovirus 2, ORF2 capsid protein, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 16:40
Veterinary medicines European public assessment report (EPAR): Cirbloc M Hyo, mycoplasma hyopneumoniae, strain 2940, inactivated,porcine circovirus 2, ORF2 capsid protein, Status: Authorised
EMA risk management information day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 November 2024, 13:30 (CET) to 21 November 2024, 17:30 (CET)
Submitted by Anonymous (not verified) on 5 November 2024 - 16:30
EMA risk management information day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 November 2024, 13:30 (CET) to 21 November 2024, 17:30 (CET)
Nominations to the Network Portfolio Advisory Group
Submitted by Anonymous (not verified) on 5 November 2024 - 16:03
Nominations to the Network Portfolio Advisory Group
Stakeholder participation in information management
Submitted by Anonymous (not verified) on 5 November 2024 - 15:43
Stakeholder participation in information management
Veterinary medicines European public assessment report (EPAR): Nobivac DP Plus, Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 15:02
Veterinary medicines European public assessment report (EPAR): Nobivac DP Plus, Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 14:36
Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised